Markedly elevated plasma myeloperoxidase protein in patients with pelvic inflammatory disease who have A allele myeloperoxidase gene polymorphism  Shun-An Lee, M.D., Po-Hui Wang, M.D., Ph.D., Hui-Ling Chiou, Ph.D., Ming-Chin Chou, M.D., Ph.D., Hsiu-Ting Tsai, Ph.D., Shun-Fa Yang, Ph.D.  Fertility and Sterility  Volume 93, Issue 4, Pages 1260-1266 (March 2010) DOI: 10.1016/j.fertnstert.2008.11.024 Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Significantly different (P<.0001) expression of plasma myeloperoxidase was shown between 50 healthy women and 44 patients with pelvic inflammatory disease before they received treatment; as well, there was a significantly different (P<.0001) expression of myeloperoxidase between pretreatment and posttreatment plasma in PID patients. There was no significant difference in myeloperoxidase concentration (P=.51) between healthy women and PID patients after receiving treatment. #The significant difference was analyzed by Mann-Whitney U test. ##The significant difference was analyzed by Wilcoxon signed-rank test. Fertility and Sterility 2010 93, 1260-1266DOI: (10.1016/j.fertnstert.2008.11.024) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 2 (A) There was a significant correlation between plasma myeloperoxidase and WBCs (Spearman correlation coefficients r = .719, P<.0001, n = 44), as well as a significant correlation between myeloperoxidase and neutrophils (r = .709, P<.0001, n = 44). (B) There was a significant correlation between plasma myeloperoxidase concentration and C-reactive protein (Spearman correlation coefficients r = .466, P=.002, n = 44). Fertility and Sterility 2010 93, 1260-1266DOI: (10.1016/j.fertnstert.2008.11.024) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions